A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Clinical trial NCT01975831 · COMPLETED

Trial details

NCT number: NCT01975831
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Ovarian Cancer Colorectal Cancer Cervical Cancer Renal Cell Carcinoma

Start date: 2013-12-19
Primary completion: 2019-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.